top of page
The Professional Network for Healthcare Experts
FDA clears PrecivityAD2 Alzheimer’s blood test for symptomatic adults aged 40 and older
The clearance extends FDA-authorised blood-based assessment of Alzheimer’s-associated amyloid pathology to younger symptomatic adults, providing clinicians with a less invasive alternative to PET imaging and cerebrospinal fluid testing.
nuaxia
12 hours ago2 min read
FDA approves TAUKLARIFY as new tau PET imaging agent for Alzheimer's disease evaluation
The approval provides clinicians with a new PET imaging agent to identify tau neurofibrillary tangle pathology in adults undergoing assessment for Alzheimer's disease, complementing existing diagnostic tools.
nuaxia
4 days ago2 min read
bottom of page